FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912878867> ?p ?o ?g. }

• W2912878867 endingPage "234" @default.
• W2912878867 startingPage "225" @default.
• W2912878867 abstract "Background Levomilnacipran extended release (ER) is a serotonin and norepinephrine reuptake inhibitor approved for major depressive disorder (MDD) in adults. This study was designed to evaluate relapse prevention with levomilnacipran ER in patients with MDD. Methods Patients (≥18 years) with MDD (N = 644) received 20 weeks of open-label treatment with levomilnacipran ER 40, 80, or 120 mg/d (8 weeks flexible dosing; 12 weeks fixed dosing). Patients with a Montgomery-Asberg Depression Rating Scale (MADRS) total score ≤12 from the end of week 8 to week 20 were randomized to 26 weeks of double-blind treatment with levomilnacipran ER (same dosage; n = 165) or placebo (n = 159). The primary efficacy endpoint was time to relapse, defined as insufficient therapeutic response (≥2-point increase from randomization in Clinical Global Impression of Severity score, risk of suicide, need for hospitalization due to worsening of depression, or need for alternative antidepressant treatment as determined by the investigator) or an MADRS total score ≥18 at 2 consecutive visits. Results In the double-blind intent-to-treat population, levomilnacipran ER-treated patients had a significantly longer time to relapse compared with placebo (hazard ratio = 0.56; 95% CI, 0.33-0.92; P = 0.0212). Crude relapse rates were 14.5% (levomilnacipran ER) and 24.5% (placebo). Double-blind treatment-emergent adverse events (AEs) were reported for 58.8% and 56.0% of levomilnacipran ER and placebo patients, respectively; 3.0% and 1.3% discontinued due to AEs, and 1.2% and 0.6% had serious AEs, respectively. Conclusion Levomilnacipran ER (40-120 mg/d) was effective in preventing relapse in patients with MDD. Safety and tolerability results were consistent with levomilnacipran ER acute studies." @default.
• W2912878867 created "2019-02-21" @default.
• W2912878867 creator A5013825927 @default.
• W2912878867 creator A5033804720 @default.
• W2912878867 creator A5046504124 @default.
• W2912878867 creator A5047183896 @default.
• W2912878867 creator A5085107940 @default.
• W2912878867 date "2019-01-23" @default.
• W2912878867 modified "2023-10-13" @default.
• W2912878867 title "Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study" @default.
• W2912878867 cites W1867335213 @default.
• W2912878867 cites W1913659607 @default.
• W2912878867 cites W1919874151 @default.
• W2912878867 cites W1967591091 @default.
• W2912878867 cites W1968103182 @default.
• W2912878867 cites W1970541793 @default.
• W2912878867 cites W1973658723 @default.
• W2912878867 cites W1993810702 @default.
• W2912878867 cites W1995472991 @default.
• W2912878867 cites W2001014758 @default.
• W2912878867 cites W2002741313 @default.
• W2912878867 cites W2011850312 @default.
• W2912878867 cites W2046440231 @default.
• W2912878867 cites W2049226284 @default.
• W2912878867 cites W2061731424 @default.
• W2912878867 cites W2066283885 @default.
• W2912878867 cites W2090877369 @default.
• W2912878867 cites W2118822483 @default.
• W2912878867 cites W2131823335 @default.
• W2912878867 cites W2132324173 @default.
• W2912878867 cites W2133308299 @default.
• W2912878867 cites W2148083007 @default.
• W2912878867 cites W2150325627 @default.
• W2912878867 cites W2150355913 @default.
• W2912878867 cites W2171166616 @default.
• W2912878867 cites W2235189311 @default.
• W2912878867 cites W2397665628 @default.
• W2912878867 cites W2546247999 @default.
• W2912878867 doi "https://doi.org/10.1002/da.22872" @default.
• W2912878867 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6590342" @default.
• W2912878867 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30675739" @default.
• W2912878867 hasPublicationYear "2019" @default.
• W2912878867 type Work @default.
• W2912878867 sameAs 2912878867 @default.
• W2912878867 citedByCount "6" @default.
• W2912878867 countsByYear W29128788672020 @default.
• W2912878867 countsByYear W29128788672021 @default.
• W2912878867 countsByYear W29128788672022 @default.
• W2912878867 countsByYear W29128788672023 @default.
• W2912878867 crossrefType "journal-article" @default.
• W2912878867 hasAuthorship W2912878867A5013825927 @default.
• W2912878867 hasAuthorship W2912878867A5033804720 @default.
• W2912878867 hasAuthorship W2912878867A5046504124 @default.
• W2912878867 hasAuthorship W2912878867A5047183896 @default.
• W2912878867 hasAuthorship W2912878867A5085107940 @default.
• W2912878867 hasBestOaLocation W29128788671 @default.
• W2912878867 hasConcept C118552586 @default.
• W2912878867 hasConcept C126322002 @default.
• W2912878867 hasConcept C142724271 @default.
• W2912878867 hasConcept C15744967 @default.
• W2912878867 hasConcept C168563851 @default.
• W2912878867 hasConcept C169900460 @default.
• W2912878867 hasConcept C1862650 @default.
• W2912878867 hasConcept C204787440 @default.
• W2912878867 hasConcept C27081682 @default.
• W2912878867 hasConcept C2780051608 @default.
• W2912878867 hasConcept C2991744798 @default.
• W2912878867 hasConcept C2992435398 @default.
• W2912878867 hasConcept C71924100 @default.
• W2912878867 hasConceptScore W2912878867C118552586 @default.
• W2912878867 hasConceptScore W2912878867C126322002 @default.
• W2912878867 hasConceptScore W2912878867C142724271 @default.
• W2912878867 hasConceptScore W2912878867C15744967 @default.
• W2912878867 hasConceptScore W2912878867C168563851 @default.
• W2912878867 hasConceptScore W2912878867C169900460 @default.
• W2912878867 hasConceptScore W2912878867C1862650 @default.
• W2912878867 hasConceptScore W2912878867C204787440 @default.
• W2912878867 hasConceptScore W2912878867C27081682 @default.
• W2912878867 hasConceptScore W2912878867C2780051608 @default.
• W2912878867 hasConceptScore W2912878867C2991744798 @default.
• W2912878867 hasConceptScore W2912878867C2992435398 @default.
• W2912878867 hasConceptScore W2912878867C71924100 @default.
• W2912878867 hasFunder F4320332585 @default.
• W2912878867 hasIssue "3" @default.
• W2912878867 hasLocation W29128788671 @default.
• W2912878867 hasLocation W29128788672 @default.
• W2912878867 hasLocation W29128788673 @default.
• W2912878867 hasOpenAccess W2912878867 @default.
• W2912878867 hasPrimaryLocation W29128788671 @default.
• W2912878867 hasRelatedWork W1986231876 @default.
• W2912878867 hasRelatedWork W2029338556 @default.
• W2912878867 hasRelatedWork W2039812143 @default.
• W2912878867 hasRelatedWork W2066505424 @default.
• W2912878867 hasRelatedWork W2121017483 @default.
• W2912878867 hasRelatedWork W2543395152 @default.
• W2912878867 hasRelatedWork W3118611254 @default.
• W2912878867 hasRelatedWork W4232533678 @default.
• W2912878867 hasRelatedWork W4236060555 @default.

• next